EA200600252A1 - Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида - Google Patents

Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида

Info

Publication number
EA200600252A1
EA200600252A1 EA200600252A EA200600252A EA200600252A1 EA 200600252 A1 EA200600252 A1 EA 200600252A1 EA 200600252 A EA200600252 A EA 200600252A EA 200600252 A EA200600252 A EA 200600252A EA 200600252 A1 EA200600252 A1 EA 200600252A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxy
phenyl
methilisoxazole
benzolsulphonamide
relates
Prior art date
Application number
EA200600252A
Other languages
English (en)
Other versions
EA008664B1 (ru
Inventor
Янош Фишер
Тамаш Фодор
Эгон Карпати
Иштванне Киш-Варга
Шандор Левай
Петер Эрдейи
Мария Зайерне Балаж
Анико Гере
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of EA200600252A1 publication Critical patent/EA200600252A1/ru
Publication of EA008664B1 publication Critical patent/EA008664B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Изобретение относится к новым сольватам N-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида формулы (I), где n равен 0 или 1 моль, сольват представляет воду, (С-С)-спирт, (С-С)-алкилэфир (С-С)-карбоновой кислоты или диоксан, и смеси сольватированных (где n=1) и несольватированных форм (где n=0). Кроме того, изобретение относится к способу их получения и их применению для лечения остеоартрита и ревматоидного артрита и болей при операции и первичной дисменореи, основанном на противовоспалительном и аналгезирующем фармакологическом действии, выявленном в экспериментах на моделях.
EA200600252A 2003-07-16 2004-07-16 Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида EA008664B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302219A HUP0302219A2 (hu) 2003-07-16 2003-07-16 N-hidroxi-4-(3-fenil-5-metil-izoxazol-4-il)-benzolszulfonamid-szolvátok, eljárás előállításukra és alkalmazásuk
PCT/HU2004/000077 WO2005007620A2 (en) 2003-07-16 2004-07-16 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates

Publications (2)

Publication Number Publication Date
EA200600252A1 true EA200600252A1 (ru) 2006-06-30
EA008664B1 EA008664B1 (ru) 2007-06-29

Family

ID=89981516

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600252A EA008664B1 (ru) 2003-07-16 2004-07-16 Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида

Country Status (9)

Country Link
US (1) US20070093539A1 (ru)
EP (1) EP1643992A2 (ru)
JP (1) JP2007530424A (ru)
CN (1) CN1805744B (ru)
CA (1) CA2530175A1 (ru)
EA (1) EA008664B1 (ru)
HU (1) HUP0302219A2 (ru)
UA (1) UA83499C2 (ru)
WO (1) WO2005007620A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
EP2145944B1 (en) 2008-07-14 2014-03-26 The Procter & Gamble Company A particle for imparting a fabric-softening benefit to fabrics treated therewith and that provides a desirable suds suppresion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL185544B1 (pl) * 1995-02-13 2003-05-30 Nowa pochodna podstawionego izoksazolu i środek farmaceutyczny
IL161086A0 (en) * 2001-10-02 2004-08-31 Pharmacia Corp Method for preparing benzenesulfonyl compounds

Also Published As

Publication number Publication date
CN1805744B (zh) 2010-11-03
WO2005007620A2 (en) 2005-01-27
CA2530175A1 (en) 2005-01-27
WO2005007620A3 (en) 2005-03-10
EA008664B1 (ru) 2007-06-29
UA83499C2 (en) 2008-07-25
JP2007530424A (ja) 2007-11-01
EP1643992A2 (en) 2006-04-12
HUP0302219A2 (hu) 2005-03-29
US20070093539A1 (en) 2007-04-26
CN1805744A (zh) 2006-07-19
HU0302219D0 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
ATE361300T1 (de) Derivate von heteroarylnitrilverbindungen
EA200701302A1 (ru) 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы
GB0121033D0 (en) Organic compounds
ATE377004T1 (de) Proteinkinaseinhibitoren
LU91024I2 (fr) Valdecoxib ou ses sels pharmaceutiquement acceptables
GB2398781B (en) Kinase inhibitors
MXPA04001930A (es) Inhibidores de proteasa de cisteina con estructura de 2-ciano-4amino-pirimidina y actividad inhibidora de catepsina k para el tratamiento de inflaciones y otras enfermedades.
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
DK1601677T3 (da) Spirosubstituerede pyrrolopyrimidiner
EA200700488A1 (ru) S-ТРИАЗОЛИЛ-α-МЕРКАПТОАЦЕТАНИЛИДЫ КАК ИНГИБИТОРЫ ОБРАТНОЙ ТРАНСКРИПТАЗЫ ВИЧ
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ATE327744T1 (de) Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
EA200601802A1 (ru) Производные морфолина
ATE511801T1 (de) Nähinstrument und -verfahren
ATE250063T1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
EA200600252A1 (ru) Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида
EA200500261A1 (ru) Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
HUP0400924A2 (hu) 2,5-Dihidroxi-benzolszulfonsav-származékok alkalmazása gyógyszerkészítmények előállítására merevedési zavarok kezelésére alkalmas más hatóanyagok hatékonyságának fokozása érdekében
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
TR200100927A2 (tr) 4-[4-(Metilsulfonil)fenil]-3-fenilfuran-2(5H)-on'un Hazırlanması için proses
EA200400276A1 (ru) Способ лечения ревматоидного артрита коленного сустава
UA41755A (uk) Спосіб ендоскопічного лікування ендометріозу дугласової кишені

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU